Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · Real-Time Price · USD

25.21

+0.85 (3.49%)

At close: Oct 7, 2025, 4:00 PM EDT

25.21

0.00 (0.00%)

After-hours: Oct 7, 2025, 4:20 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EMPAVELI Revenue	88.46M	98.09M	Log In	Log In	Log In
SYFOVRE Revenue	600.57M	611.86M	Log In	Log In	Log In
Total Product Revenue	689.03M	709.95M	Log In	Log In	Log In
Licensing and Other Revenue	65.62M	71.41M	Log In	Log In	Log In
Revenue (Other)	-1.00K	-	Log In	Log In	Log In
Revenue (Total)	754.65M	781.37M	Log In	Log In	Log In

Updated Jul 31, 2025. Data Source: Fiscal.ai.